We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cephalon Settles Off-Label Drug Marketing Suits for $444 Million
Cephalon Settles Off-Label Drug Marketing Suits for $444 Million
September 29, 2008
Cephalon has agreed to a $444 million settlement of federal and state investigations in which officials accuse it of off-label marketing of three drugs.